title: Clinicopathologic study in uterine cancer.
abstract: Patients with primary advanced or recurrent endometrial cancer are relatively uncommon and deserve better treatment options. Current treatment options are surgery, radiotherapy, and systemic therapy. Since the outcome is still poor, there is a need to improve our knowledge on molecular markers in order to personalize treatment. In addition, we need to continue the search for new treatment strategies with a better balance between efficacy and toxicity. In this doctoral thesis, we documented that among molecular and histological markers, blood vessel space involvement and chemotherapy induced regressive changes are new prognostic markers in endometrial cancer. We demonstrated that the tumour biology changes during tumour evolution. The optimal moment to decide on tumour biology is therefore the recurrent setting. A biopsy of the recurrent tumour is the best guarantee to characterize the tumour correctly. Furthermore, this study showed that neoadjuvant chemotherapy followed by interval debulking is a valuable treatment option for endometrial cancer with transperitoneal spread since optimal cytoreduction was achieved in 78% with a low morbidity. Future studies should look into new biomarkers that predict antitumoral activity and should search for mutations in endometrial cancer and analyse which mutation is sensitive for therapy.
authors.affiliation: Leuven Cancer Institute (LKI), Gynecologic Oncology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.
authors.forename: I
authors.initials: I
authors.lastname: Vandenput
keywords: Endometrial cancer; new treatment strategies; prognostic markers; tumour biology
references.citation: Int J Gynecol Cancer. 2007 Jan-Feb;17(1):197-203
references.pmid: 17291253
references.citation: Pathol Int. 2009 Dec;59(12):863-7
references.pmid: 20021611
references.citation: J Clin Oncol. 2004 Aug 1;22(15):3126-32
references.pmid: 15284264
references.citation: Gynecol Oncol. 1997 Oct;67(1):56-60
references.pmid: 9345357
references.citation: Int J Gynaecol Obstet. 2008 Aug;102(2):128-31
references.pmid: 18555254
references.citation: Gynecol Oncol. 2004 Feb;92(2):653-9
references.pmid: 14766262
references.citation: Int J Gynecol Cancer. 2002 Sep-Oct;12(5):454-8
references.pmid: 12366662
references.citation: Gynecol Oncol. 2005 Jan;96(1):210-5
references.pmid: 15589603
references.citation: Histopathology. 2009 Jan;54(2):174-83
references.pmid: 19207942
references.citation: Gynecol Oncol. 1983 Feb;15(1):10-7
references.pmid: 6822361
references.citation: Gynecol Oncol. 2009 Nov;115(2):244-8
references.pmid: 19712966
references.citation: Int J Gynecol Cancer. 2008 Jul-Aug;18(4):820-4
references.pmid: 17892450
references.citation: Gynecol Oncol. 2010 Jan;116(1):15-20
references.pmid: 19840887
references.citation: Am J Surg Pathol. 1995 Jun;19(6):666-74
references.pmid: 7755153
references.citation: Gynecol Oncol. 1999 Apr;73(1):140-4
references.pmid: 10094895
references.citation: CA Cancer J Clin. 1999 Jan-Feb;49(1):33-64, 1
references.pmid: 10200776
references.citation: Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:273-7
references.pmid: 16515603
references.citation: Int J Gynecol Pathol. 2003 Apr;22(2):149-55
references.pmid: 12649669
references.citation: Gynecol Oncol. 2007 Nov;107(2):190-3
references.pmid: 17825394
references.citation: Lung Cancer. 2009 Jun;64(3):326-33
references.pmid: 18977553
references.citation: Int J Gynecol Cancer. 2008 Jan-Feb;18(1):14-21
references.pmid: 17451461
references.citation: Gynecol Oncol. 2001 Apr;81(1):92-9
references.pmid: 11277657
references.citation: Gynecol Oncol. 2009 Jan;112(1):142-5
references.pmid: 19019418
references.citation: Int J Gynecol Pathol. 1990;9(1):1-19
references.pmid: 2152890
references.citation: Int J Gynecol Cancer. 2006 May-Jun;16(3):1370-3
references.pmid: 16803532
references.citation: Cancer Treat Rev. 1998 Oct;24(5):331-44
references.pmid: 9861196
references.citation: Nat Med. 2004 Aug;10(8):789-99
references.pmid: 15286780
references.citation: Gynecol Oncol. 1999 Jun;73(3):461-3
references.pmid: 10366480
references.citation: Hum Pathol. 1998 May;29(5):498-504
references.pmid: 9596274
references.citation: Gynecol Oncol. 2011 Jan;120(1):43-6
references.pmid: 21040953
references.citation: Lung Cancer. 2008 Oct;62(1):105-12
references.pmid: 18395930
references.citation: APMIS. 2009 Oct;117(10):693-707
references.pmid: 19775337
references.citation: Gynecol Oncol. 2007 Jun;105(3):677-82
references.pmid: 17355889
references.citation: Gynecol Oncol. 1998 Apr;69(1):69-73
references.pmid: 9571001
references.citation: Gynecol Oncol. 2005 Mar;96(3):799-804
references.pmid: 15721428
references.citation: N Engl J Med. 2006 Sep 7;355(10):983-91
references.pmid: 16957145
references.citation: Gynecol Oncol. 2004 Jun;93(3):653-8
references.pmid: 15196860
references.citation: Gynecol Oncol. 2003 Mar;88(3):263-5
references.pmid: 12648572
references.citation: Gynecol Oncol. 2003 Dec;91(3):463-9
references.pmid: 14675663
references.citation: Gynecol Oncol. 2010 May;117(2):234-8
references.pmid: 20153885
references.citation: Gynecol Oncol. 2005 Dec;99(3):557-63
references.pmid: 16154185
references.citation: Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1897-902
references.pmid: 17009989
references.citation: Br J Cancer. 2006 Dec 18;95(12):1611-25
references.pmid: 17117184
references.citation: Endocr Relat Cancer. 2009 Jun;16(2):363-80
references.pmid: 19190080
references.citation: Pathology. 2009 Jan;41(1):89-99
references.pmid: 19089744
references.citation: World J Surg Oncol. 2010 Oct 14;8:89
references.pmid: 20946633
references.citation: Curr Cancer Drug Targets. 2003 Feb;3(1):21-9
references.pmid: 12570658
references.citation: Gynecol Oncol. 1991 Aug;42(2):142-5
references.pmid: 1894173
references.citation: Cancer Sci. 2007 Sep;98(9):1336-43
references.pmid: 17640298
references.citation: Science. 1994 Dec 23;266(5193):1954-6
references.pmid: 7801120
references.citation: J Clin Oncol. 2001 Oct 15;19(20):4048-53
references.pmid: 11600606
references.citation: Cancer Res. 2010 Jul 1;70(13):5486-96
references.pmid: 20530669
references.citation: Gynecol Oncol. 1994 Feb;52(2):237-40
references.pmid: 8314145
references.citation: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references.pmid: 20610543
references.citation: Hum Pathol. 2007 Jun;38(6):926-34
references.pmid: 17397905
references.citation: Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:442-5
references.pmid: 16515642
references.citation: J Mol Diagn. 2005 May;7(2):149-51
references.pmid: 15858137
references.citation: Gynecol Oncol. 2005 Mar;96(3):651-7
references.pmid: 15721407
references.citation: Gynecol Oncol. 2004 Jan;92(1):240-6
references.pmid: 14751165
references.citation: Gynecol Oncol. 2007 Nov;107(2):186-9
references.pmid: 17688926
references.citation: Gynecol Oncol. 2005 Sep;98(3):353-9
references.pmid: 16005947
references.citation: Int J Gynecol Cancer. 2006 May-Jun;16(3):986-90
references.pmid: 16803473
references.citation: Lancet Oncol. 2009 Oct;10(10):933-5
references.pmid: 19796747
references.citation: Cancer Chemother Pharmacol. 2009 Aug;64(3):565-73
references.pmid: 19123003
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):119-22
references.pmid: 17218243
references.citation: Br J Cancer. 2010 Jan 5;102(1):134-43
references.pmid: 19920829
references.citation: Int J Gynecol Cancer. 2011 Jan;21(1):72-8
references.pmid: 21178572
references.citation: Gynecol Oncol. 1996 Jul;62(1):123-7
references.pmid: 8690284
references.citation: Lancet Oncol. 2008 Feb;9(2):168-75
references.pmid: 18237851
references.citation: Drug Resist Updat. 2002 Jul-Aug;5(3-4):147-61
references.pmid: 12237082
references.citation: Arch Pathol Lab Med. 2001 Jan;125(1):146-51
references.pmid: 11151069
references.citation: Gynecol Oncol. 2001 May;81(2):279-86
references.pmid: 11330963
references.citation: Lancet. 2005 Aug 6-12;366(9484):491-505
references.pmid: 16084259
references.citation: Am J Surg Pathol. 1990 Apr;14(4):317-28
references.pmid: 2157343
references.citation: Gynecol Oncol. 2003 Dec;91(3):470-5
references.pmid: 14675664
references.citation: Gynecol Oncol. 2005 Jul;98(1):24-30
references.pmid: 15894362
references.citation: Gynecol Oncol. 2004 Oct;95(1):32-6
references.pmid: 15385107
references.citation: Int J Gynecol Cancer. 2005 Sep-Oct;15(5):974-8
references.pmid: 16174254